Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Other Non-Current Liabilities (2022 - 2026)

Heron Therapeutics filings provide 5 years of Other Non-Current Liabilities readings, the most recent being $4.9 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 622.73% to $4.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.9 million, a 622.73% increase, with the full-year FY2025 number at $4.8 million, up 681.79% from a year prior.
  • Other Non-Current Liabilities hit $4.9 million in Q1 2026 for Heron Therapeutics, up from $4.8 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $4.9 million in Q1 2026 to a low of $241000.0 in Q1 2022.
  • Median Other Non-Current Liabilities over the past 5 years was $241000.0 (2022), compared with a mean of $1.1 million.
  • Biggest five-year swings in Other Non-Current Liabilities: changed 0.0% in 2023 and later skyrocketed 1847.72% in 2025.
  • Heron Therapeutics' Other Non-Current Liabilities stood at $241000.0 in 2022, then changed by 0.0% to $241000.0 in 2023, then soared by 155.19% to $615000.0 in 2024, then soared by 681.79% to $4.8 million in 2025, then increased by 2.52% to $4.9 million in 2026.
  • The last three reported values for Other Non-Current Liabilities were $4.9 million (Q1 2026), $4.8 million (Q4 2025), and $4.7 million (Q3 2025) per Business Quant data.